跳至主要内容
临床试验/ISRCTN71141922
ISRCTN71141922已完成未知

Antibiotic targeting of wolbachia endosymbiotic bacteria as a new approach to the treatment of filarial (Onchocerca Volvulus) infection and disease

European Commission (Belgium)0 个研究点目标入组 67 人开始时间: 2006年7月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
67

研究概览

简要总结

2008 results in: https://www.ncbi.nlm.nih.gov/pubmed/17999080 (added 09/05/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • All male or female subjects, aged 18-50 years, who have given informed consent (written or thumb print) were evaluated. Minimum body weight criteria is >40 kg. Participants were then included only if they met the following criteria:
  • 1. Normal renal and hepatic laboratory profiles for aspartate aminotransferase (AST) (0-40 IU/l), alanine aminotransferase (ALT) (0-45 IU/l)
  • 2. Creatinine 53-126 µmol/l as measured by dipstick chemistry
  • 3. More than two palpable onchocercomas
  • 4. Microfilarial (Mf) counts >10 Mf/mg (skin biopsies)

排除标准

  • 1. Pregnancy (pregnancy test)
  • 2. Lactation
  • 3. Intolerance to ivermectin or doxycycline
  • 4. Chronic diseases
  • 5. Alcohol or drug abuse
  • 6. Anti-filarial therapy within the last two years

研究者

发起方
European Commission (Belgium)

相似试验